Patients can access weight management care for $49 per visit, no monthly subscription needed DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens announced today the launchPatients can access weight management care for $49 per visit, no monthly subscription needed DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens announced today the launch

Walgreens Virtual Healthcare Adds Weight Management Services to Support Patients on Their Weight Loss Journey

2026/02/26 23:03
Okuma süresi: 4 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen [email protected] üzerinden bizimle iletişime geçin.

Patients can access weight management care for $49 per visit, no monthly subscription needed

DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens announced today the launch of Walgreens Weight Management, a new digital healthcare offering designed to help eligible adults access personalized, clinician-guided support for weight loss. This expands Walgreens’ Virtual Healthcare platform and provides patients with convenient access to licensed doctors and nurse practitioners, FDA-approved medication options and ongoing support from the comfort of their home. The program is intended for eligible overweight and obese adults ages 18-64 who plan to self-pay for their GLP-1 medication.

As part of the new program, eligible patients can complete an online video visit with a licensed doctor or nurse practitioner who evaluates their health history, weight related goals and medical needs. Providers may prescribe FDA-approved GLP-1s for weight loss for eligible overweight or obese patients that are starting or continuing their weight loss journey using a GLP-1. The program offers on-demand follow-up visits via chat or video for medication adjustments and side effect management between 7 a.m. and 11 p.m. CT, 7 days a week.

Walgreens has also expanded its Rx Savings Finder tool, powered by RxSense, to include Novo Nordisk’s reduced price starting at $149 per month for the recently launched Wegovy ® (semaglutide) 1.5 mg or 4 mg tablet and $199 per month for the Wegovy ® 0.25 mg and 0.5 mg injectable.1 Learn about the terms and conditions of this reduced price offer on the Walgreens Weight Management page here.

“Expanding our virtual healthcare platform to include weight management is part of our ongoing commitment to listening to patients and the services they want from their local pharmacy,” said Rick Gates, Chief Pharmacy Officer, Walgreens. “By combining trusted clinical expertise with the reach of our digital and pharmacy network, we’re helping eligible patients take meaningful steps toward better health, on their own terms.”

Less than 1 in 4 employers surveyed by KFF in 2025 covered GLP-1s for weight loss when used primarily for weight management.2 Walgreens Weight Management is a more affordable option than other telehealth subscriptions for patients who do not have GLP-1 coverage via their employers.

The program is accessible in most states and is designed to integrate seamlessly with Walgreens’ pharmacy services. Patients can send their prescription to the pharmacy of their choice. All visits are $49 with no monthly subscription needed.

Patients interested in learning more about Walgreens Weight Management and/or determining eligibility can do so here: Walgreens Weight Management.

Currently available in the following states: AZ, CA, CO, CT, FL, GA, IL, IN, KS, KY, MA, MD, MI, MN, MO, NC, NJ, NV, NY, OH, OK, PA, SC, TN, TX, VA, WA, WI.

Wegovy ® (semaglutide) is a prescription medication.

Wegovy® may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.

Do not use Wegovy® if:

  • you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® injection or Wegovy® tablets.

The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.[1]

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

About Walgreens

Founded in 1901, Walgreens (www.walgreens.com) proudly serves more than 9 million customers and patients each day across its nearly 8,000 stores throughout the U.S. and Puerto Rico. Walgreens has approximately 211,000 team members, including roughly 85,000 healthcare service providers, and is committed to being the first choice for pharmacy, retail and health services, building trusted relationships that create healthier futures for customers, patients, team members and communities.

References:

1 Wegovy prescribing information: https://www.novo-pi.com/wegovy.pdf

2 Kaiser Family Foundation. (2025, October 22). 2025 Employer Health Benefits Survey. Kaiser Family Foundation. https://www.kff.org/health-costs/2025-employer-health-benefits-survey/

Contacts

Media Contact
Carmen Lopez
[email protected]

Piyasa Fırsatı
Virtuals Protocol Logosu
Virtuals Protocol Fiyatı(VIRTUAL)
$0.6267
$0.6267$0.6267
-1.21%
USD
Virtuals Protocol (VIRTUAL) Canlı Fiyat Grafiği

Get Covered, Share 1M USDT

Get Covered, Share 1M USDTGet Covered, Share 1M USDT

Higher VVIP tiers, higher compensation odds.

Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Metaplanet buys 5,075 Bitcoin in Q1 to become 3rd-largest treasury

Metaplanet buys 5,075 Bitcoin in Q1 to become 3rd-largest treasury

Metaplanet lifted its Bitcoin holdings to 40,177 in Q1 after buying over $400 million of BTC to become the third-largest BTC treasury.
Paylaş
Coin Telegraph2026/04/02 18:04
The changing face of elder care in Malaysia — Sayed Mohammad Reza Yamani Sayed Umar

The changing face of elder care in Malaysia — Sayed Mohammad Reza Yamani Sayed Umar

JULY 10 — An elderly society is becoming increasingly prevalent in Malaysia at present. It is projected that the p...
Paylaş
Malaymail2026/07/10 15:24
New Trump appointee Miran calls for half-point cut in only dissent as rest of Fed bands together

New Trump appointee Miran calls for half-point cut in only dissent as rest of Fed bands together

The post New Trump appointee Miran calls for half-point cut in only dissent as rest of Fed bands together appeared on BitcoinEthereumNews.com. Stephen Miran, chairman of the Council of Economic Advisers and US Federal Reserve governor nominee for US President Donald Trump, arrives for a Senate Banking, Housing, and Urban Affairs Committee confirmation hearing in Washington, DC, US, on Thursday, Sept. 4, 2025. The Senate Banking Committee’s examination of Stephen Miran’s appointment will provide the first extended look at how prominent Republican senators balance their long-standing support of an independent central bank against loyalty to their party leader. Photographer: Daniel Heuer/Bloomberg via Getty Images Daniel Heuer | Bloomberg | Getty Images Newly-confirmed Federal Reserve Governor Stephen Miran dissented from the central bank’s decision to lower the federal funds rate by a quarter percentage point on Wednesday, choosing instead to call for a half-point cut. Miran, who was confirmed by the Senate to the Fed Board of Governors on Monday, was the sole dissenter in the Federal Open Market Committee’s statement. Governors Michelle Bowman and Christopher Waller, who had dissented at the Fed’s prior meeting in favor of a quarter-point move, were aligned with Fed Chair Jerome Powell and the others besides Miran this time. Miran was selected by Trump back in August to fill the seat that was vacated by former Governor Adriana Kugler after she suddenly announced her resignation without stating a reason for doing so. He has said that he will take an unpaid leave of absence as chair of the White House’s Council of Economic Advisors rather than fully resign from the position. Miran’s place on the board, which will last until Jan. 31, 2026 when Kugler’s term was due to end, has been viewed by critics as a threat from Trump to the Fed’s independence, as the president has nominated three of the seven members. Trump also said in August that he had fired Federal Reserve Board Governor…
Paylaş
BitcoinEthereumNews2025/09/18 02:26

Record Ads, Stock Down 7%

Record Ads, Stock Down 7%Record Ads, Stock Down 7%

Jul 29: Meta earnings face the market's question.